Alkermes plc - Ordinary Shares (NQ:ALKS)

42.66 +0.91 (+2.19%)

Delayed Quote Updated: 10:09 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alkermes plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

NASDAQ:ALKS is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗

January 22, 2025

When you look at ALKERMES PLC (NASDAQ:ALKS), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Via Chartmill

Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued. ↗

December 31, 2024

ALKERMES PLC (NASDAQ:ALKS) appears to be flying under the radar despite its strong fundamentals.

Via Chartmill

NASDAQ:ALKS, an undervalued stock with good fundamentals. ↗

December 10, 2024

ALKERMES PLC (NASDAQ:ALKS): good value for what you're paying.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 19, 2024

Via Benzinga

NASDAQ:ALKS: good value for what you're paying. ↗

November 18, 2024

Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 05, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts ↗

November 05, 2024

Via Benzinga

NASDAQ:ALKS is an undervalued gem with solid fundamentals. ↗

October 28, 2024

ALKERMES PLC (NASDAQ:ALKS), an undervalued stock with good fundamentals.

Via Chartmill

Alkermes's Earnings: A Preview ↗

October 23, 2024

Via Benzinga

Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits ↗

October 14, 2024

Alkermes develops treatments for neurodegenerative diseases (conditions that damage and destroy parts of the nervous system) and cancer.

Via Investor's Business Daily

Decoding 7 Analyst Evaluations For Alkermes ↗

October 10, 2024

Via Benzinga

Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued. ↗

October 04, 2024

ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

September 16, 2024

Via Benzinga

NASDAQ:ALKS: good value for what you're paying. ↗

September 13, 2024

For those who appreciate value investing, ALKERMES PLC (NASDAQ:ALKS) is a compelling option with its solid fundamentals.

Via Chartmill

Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued. ↗

August 23, 2024

For those who appreciate value investing, ALKERMES PLC (NASDAQ:ALKS) is a compelling option with its solid fundamentals.

Via Chartmill

6 Analysts Assess Alkermes: What You Need To Know ↗

July 15, 2024

Via Benzinga

The Analyst Landscape: 7 Takes On Alkermes ↗

June 17, 2024

Via Benzinga

6 Analysts Assess Alkermes: What You Need To Know ↗

May 23, 2024

Via Benzinga

NASDAQ:ALKS stands out as a stock that provides good value for the fundamentals it showcases. ↗

August 02, 2024

Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 24, 2024

Via Benzinga

ALKS Stock Earnings: Alkermes Beats EPS, Beats Revenue for Q2 2024 ↗

July 24, 2024

ALKS stock results show that Alkermes beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

7 Analysts Assess Alkermes: What You Need To Know ↗

May 02, 2024

Via Benzinga

Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS). ↗

May 02, 2024

Should you consider ALKERMES PLC (NASDAQ:ALKS) for growth investing?

Via Chartmill

AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday ↗

July 24, 2024

Via Benzinga

"Rule Breaker Investing" Stock Pick Review: The Big One ↗

July 15, 2024

Looking back at 30 five-stock samplers picked from 2015 to 2021.

Via The Motley Fool

NASDAQ:ALKS is an undervalued gem with solid fundamentals. ↗

July 11, 2024

Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.

Via Chartmill

When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗

June 19, 2024

Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag.

Via Chartmill

In a market where value is scarce, NASDAQ:ALKS offers a refreshing opportunity with its solid fundamentals. ↗

May 29, 2024

Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag.

Via Chartmill

3 Biotech Stocks That Could Be Millionaire-Makers: May Edition ↗

May 25, 2024

Investors should take a close look at these biotech stocks as they position themselves to provide high returns.

Via InvestorPlace

Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents. ↗

May 08, 2024

ALKERMES PLC (NASDAQ:ALKS) is probably undervalued for the fundamentals it is displaying.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.